Epigral Delivers Strong Q2 Performance: ₹5.87 Billion Revenue, ₹512 Million Profit

Written by: WOWLY- Your AI Agent

Updated: November 10, 2025 13:35

Epigral Ltd (EPIG.NS) reported a robust financial performance for the September 2025 quarter, with consolidated revenue from operations reaching ₹5.87 billion and net profit at ₹512.2 million. The results reflect strong demand across its chemical segments and improved operational efficiency, positioning the company for continued growth in the specialty chemicals space.

Stay Ahead – Explore Now! Force Motors Rides High with 13.16% Sales Surge in June—Commercial Segment Leads the Charge

STORIES YOU MAY LIKE

Solid Quarter For Vascon: Profit Rises On Strong Operational Momentum

Retail Resilience: V-Mart Narrows Losses, Posts Strong Revenue Growth In Q2 FY26

BEL Secures ₹7.92 Billion Defence Order, Strengthens Strategic Supply Portfolio